Skripsi
UJI AKTIVITAS ANTIDIABETES DAN ANALISIS KANDUNGAN KIMIA FRAKSI KOLOM DAUN DAN BATANG TUMBUHAN LENG-LENGAN (Leucas lavandulifolia)
Leng-lengan (Leucas lavandulifolia) is a medicinal plant that has been used in traditional medicine for the treatment of rheumatism, skin diseases, scorpion stings, wound healing, snake bites, diabetic, fever, laxative, asthma, dyspepsia and paralysis. The stems are used to treat allergies, dermatitis, asthma, psosiaris and fever. Leng-lengan leaves are usually consumed by the public as sedative for respitory tract diseases, nervous disorder, expectorant and back pain. Information on the chemical content of the L. lavandulifolia has been reported to contain compounds acacetion, chrysuriol, linifoliside, luteolin, lupeol, flavonoid glycoside, taraxeron and chrysuriol-4’-O-α-L-rhamnopyranosil-(1-6)-β-D- glucopyranoside. In addition, it has also been reported that p-hydroxybenzoic acid, p-coumaric acid, vanillic acid chrysuriol-6”-(OAc)-4'-β-glucoside in L. lavandulifolia have various biological activities such as anti-inflammatory, antimicrobial, anti-ulcer, antitussive, antioxidant, anti-diabetic and anti-wound. Base on literature studies, it was found that the chloroform extract of the flower part of the plant was reported to be active as an antidiabetic but in the stems and leaves there has been no information on compounds that related to antidiabetic. Based on this, it is necessary to conduct research on the chemical content analysis of the active antidiabetic fractions from the leaves and stems of the leng-lengan plant (L. lavandulifolia). The leaves and stems of leng-lengan were extracted by maceration use solvents with increase polarity (n-hexane, ethyl acetate and methanol). Each extract was tested for antidiabetic activity using the α-glucosidase enzyme inhibition method. The active antidiabetic extracts from the leaves and stems were then separated using chromatography techniques. Potential fractions from the separation result were identified for chemical content using Gas Chromatography- Mass Spectrometry (GC-MS) and tested for antidiabetic activity. The results showed the ethyl acetate extract of the leaves and stems had highest inhibitory activity than the other extracts with IC50 values of 5.63 μg/mL and 4.985 μg/mL. The selected column fractions of ethyl acetate extracts of F6.3 and F6.5 leave parts showed antidiabetic activity with IC50 values of 36.72 and 17.32 μg/mL respectively, which was stronger than the standard acarbose (IC50 67.07 μg/mL). Analysis of the chemical content of fraction F6.3 showed the dominant compounds: 1-Naphthalenepropanol, α-ethenyldecahydro-4-hydroxy-α,5,5,8a- tetramethyl-2-methylene and fraction F6.5: 9-Octadecanoid acid (Z)-methyl ester. Meanwhile, the selected column fraction from the stem part of E6 showed antidiabetic activity (IC50 4.37μg/mL) with the dominant chemical content of Spiro [tetrahydrofuran-2,1’-decalin], 5-methyl-2’methylene-5’,5’,8a’-trimethyl. The fraction from the stem part of L. lavandulifolia showed better antidiabetic potential compared to the fraction from the leave part. Keyword : L. lavandulifolia, antidiabetic, α-glucosidase, GCMS, IC50
No other version available